New hope for teens with schizophrenia? drug trial underway
Disease control
Recruiting now
This study tests whether cariprazine, a daily medication, can safely reduce schizophrenia symptoms in teenagers aged 13 to 17. About 330 participants will receive either cariprazine or a placebo for 6 weeks. The main goal is to see if symptoms improve compared to a placebo.
Phase: PHASE3 • Sponsor: Gedeon Richter Plc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC